. 2020 Dec 23;14:1753466620962665. doi: 10.1177/1753466620962665

Table 3.

Absolute values of the inflammatory markers.

Inflammatory markers	SAL	OVA	OVA-RHO inhibitor	OVA-anti-IL17	OVA-RHO inhibitor-anti-IL17
CD4 (cells/10⁴μm²)	0.6 ± 1.2	5.5 ± 3.2^*	2.6 ± 5.3^**	2.5 ± 5.1^,^*	2.3 ± 4.4^**
CD8 (cells/10⁴μm²)	11.2 ± 12.0	40.8 ± 22.6^*	23.9 ± 17.8^**	14.2 ± 15.1^**	9.2 ± 11.2^**,^&
IL-1β (cells/10⁴μm²)	4.7 ± 5.8	35.0 ± 31.2^*	3.9 ± 6.6^**,^#	19.1 ± 14.4^,^*	8.5 ± 9.1^**,^#
IL-4 (cells/10⁴μm²)	1.9 ± 3.6	9.2 ± 7.4^*	0.6 ± 1.8^**	2.0 ± 3.4^**	0.6 ± 1.8^**
IL-5 (cells/10⁴μm²)	2.5 ± 3.9	14.6 ± 15.3^*	2.9 ± 4.0^**	6.2 ± 8.5^**	1.8 ± 3.5^**
IL-6 (cells/10⁴μm²)	0.1 ± 0.6	5.0 ± 6.2^*	0.5 ± 1.6^**	0.4 ± 1.4^**	0.3 ± 1.2^**
IL-10 (cells/10⁴μm²)	0.9 ± 1.4	7.8 ± 9.9^*	3.5 ± 4.8^**	4.2 ± 5.3^**	3.2 ± 4.4^**
IL-13 (cells/10⁴μm²)	0.8 ± 1.6	6.8 ± 7.4^*	2.6 ± 6.3^**	1.5 ± 3.5^**	2.4 ± 3.8^**
IL-17 (cells/10⁴μm²)	1.9 ± 2.1	12.0 ± 2.8^*	7.2 ± 4.1^,^*	5.3 ± 2.7^,^*	2.9 ± 0.6^,^*,^&
TNF-α (cells/10⁴μm²)	2.7 ± 4.7	7.1 ± 5.2^*	1.6 ± 3.4^**	2.3 ± 4.0^**	1.1 ± 2.5^**

IL, interleukin; TNF, tumor necrosis factor; OVA, animals induced to chronic allergic pulmonary inflammation by ovalbumin; OVA-anti-IL17, animals with induction of chronic allergic pulmonary inflammation and use of anti-IL17; OVA-RHO inhibitor, animals with induction of chronic allergic pulmonary inflammation and use of Rho-kinase inhibitor; OVA-RHO inhibitor-anti-IL17, animals with induction of chronic allergic pulmonary inflammation and use of Rho-kinase inhibitor and anti-IL17; SAL, saline group.

p < 0.05 compared with the SAL group.

^**

p < 0.05 compared with the OVA group.

p < 0.05 compared with OVA-RHO inhibitor group.

p < 0.05 compared with OVA-anti-IL17 group.